SOW
PTCT icon

State of Wyoming’s PTC Therapeutics PTCT Stock Holding History

State of Wyoming’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Sell
1,702
-4,451
-72% -$321K 0.01% 1239
2026
Q1 		$419K Buy
+6,153
New +$436K 0.05% 441
2025
Q4 		– Sell
-10,870
Closed -$667K – 2038
2025
Q3 		$667K Buy
10,870
+7,297
+204% +$380K 0.08% 195
2025
Q2 		$175K Buy
3,573
+58
+2% +$2.75K 0.02% 1013
2025
Q1 		$179K Sell
3,515
-2,261
-39% -$113K 0.02% 872
2024
Q4 		$261K Buy
+5,776
New +$247K 0.03% 653

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

State of Wyoming's PTCT Position: Q2 2026 in Review

State of Wyoming reduced its PTC Therapeutics (PTCT) stake by 72% in Q2 2026, selling an estimated $321K and leaving 1,702 shares worth $139K. The position accounts for 0.01% of the portfolio, ranked #1239.

State of Wyoming first reported a position in PTCT in Q4 2024 and has held it in 6 quarters since. The position peaked at $667K in Q3 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • State of Wyoming held 1,702 shares of PTC Therapeutics worth $139K as of Q2 2026.
  • State of Wyoming sold 4,451 PTC Therapeutics shares in Q2 2026, an estimated $321K.
  • PTC Therapeutics made up 0.01% of State of Wyoming's portfolio in Q2 2026, its #1239 holding.
  • State of Wyoming first reported a position in PTC Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • State of Wyoming's PTC Therapeutics position peaked at $667K in Q3 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.